2m 2m 2m 2m 2m 2m 2m
Medicure (MCUJF)
OTC
$0.80-$0.04 (-4.24%)
Price as of Jun 02, 2026- $8.4MMarket Cap
- 0.92%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Medicure (MCUJF)
$0.80-$0.04 (-4.24%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 28.9M +31.72% | 21.9M +0.98% | 21.7M -5.94% | 23.1M +6.08% | |
Cost of Revenue | 17.1M +94.00% | 8.8M +14.45% | 7.7M +10.23% | 7.0M -22.61% | |
Gross Profit | 11.7M -10.25% | 13.1M -6.43% | 14.0M -12.98% | 16.1M +26.46% | |
Sales and Marketing Expense | 10.5M +31.09% | 8.0M -3.91% | 8.3M +4.68% | 7.9M -23.05% | |
Research and Development Expense | -3.2M +3.18% | -3.1M +28.05% | -2.4M -12.64% | -2.8M +53.34% | |
Depreciation and Amortization Expense | 3,000 -99.52% | 620,000 +1.47% | 611,000 +3.74% | 589,000 -68.01% | |
Total Operating Expenses | 5.0M +4.85% | 4.8M +15.32% | 4.1M -1.48% | 4.2M +55.47% | |
Operating Profit | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income | 235,000 +14.08% | 206,000 +174.67% | 75,000 +650.00% | 10,000 -87.18% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 235,000 +14.08% | 206,000 +174.67% | 75,000 +650.00% | 10,000 -87.18% | |
Total Nonoperating Income and Expense | 0 -100.00% | 1.9M +437.57% | 346,000 0.00% | 346,000 -81.07% | |
Income before Taxes | -7.1M +583.06% | -1.0M +12.69% | -922,000 -167.55% | 1.4M +287.76% | |
Income Taxes | 208,000 +181.25% | -256,000 +924.00% | -25,000 -225.00% | 20,000 +162.50% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -7.1M +583.06% | -1.0M +12.69% | -922,000 -167.55% | 1.4M +287.76% | |
Net Income from Continuing Operations Applicable to Common | -7.1M +583.06% | -1.0M +12.69% | -922,000 -167.55% | 1.4M +287.76% | |
Basic EPS and Net Income | -0.68 +580.00% | -0.10 +11.11% | -0.09 -169.23% | 0.13 +285.71% | |
Diluted EPS and Net Income | -0.68 +580.00% | -0.10 +11.11% | -0.09 -169.23% | 0.13 +285.71% | |
Basic Weighted Average Shares | 10.4M 0.00% | 10.4M 0.00% | 10.4M +1.80% | 10.3M 0.00% | |
Diluted Weighted Average Shares | 10.4M 0.00% | 10.4M 0.00% | 10.4M +1.80% | 10.3M 0.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.8M -46.67% | 7.2M +12.91% | 6.4M +31.13% | 4.9M +31.48% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.8M -46.67% | 7.2M +12.91% | 6.4M +31.13% | 4.9M +31.48% | |
Total Current Assets | 11.9M -25.22% | 15.9M +4.54% | 15.2M +2.42% | 14.8M +18.27% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 945,000 -1.05% | 955,000 +29.76% | 736,000 -37.99% | 1.2M -26.32% | |
Total Long-Term Assets | 13.1M -5.22% | 13.8M +7.23% | 12.9M -14.60% | 15.1M -5.06% | |
Total Assets | 24.9M -15.94% | 29.7M +5.77% | 28.1M -6.15% | 29.9M +5.25% | |
Income Taxes Payable | 90,000 -5.26% | 95,000 +493.75% | 16,000 N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 11.6M +38.33% | 8.4M +5.81% | 7.9M -5.44% | 8.4M -1.43% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 427,000 -15.61% | 506,000 +120.96% | 229,000 -54.47% | 503,000 -66.13% | |
Total Liabilities | 12.0M +35.27% | 8.9M +9.04% | 8.2M -8.21% | 8.9M -11.04% | |
Retained Earnings | -74.0M +10.61% | -66.9M +1.58% | -65.9M +1.42% | -64.9M -2.06% | |
Total Stockholders Equity | 12.9M -37.87% | 20.8M +4.43% | 19.9M -5.28% | 21.0M +14.09% | |
Total Shares Outstanding | 10.4M 0.00% | 10.4M 0.00% | 10.4M +1.80% | 10.3M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -560,000 -140.67% | 1.4M -33.77% | 2.1M +13.73% | 1.8M -54.17% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -2.0M +176.32% | -739,000 +173.70% | -270,000 -12.90% | -310,000 -88.49% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -415,000 +12.16% | -370,000 +24.58% | -297,000 -16.34% | -355,000 +12.34% | |
Financials Ratio | |||||
Gross Margin | 40.71% -31.86% | 59.75% -7.34% | 64.48% -7.48% | 69.69% +19.21% | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -25.98% +621.95% | -3.60% +13.12% | -3.18% -167.95% | 4.68% +301.14% | |
Return on Equity | -42.13% +724.74% | -5.11% +13.32% | -4.51% -165.09% | 6.93% +278.90% | |
Revenue Growth | 31.72% +3,130.38% | 0.98% +116.52% | -5.94% -197.84% | 6.08% -93.04% | |
Current Ratio | 1.02 -45.94% | 1.89 -1.20% | 1.92 +8.31% | 1.77 +19.98% | |
Cash Ratio | 0.33 -61.45% | 0.86 +6.71% | 0.80 +38.66% | 0.58 +33.39% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow